Neurol. praxi. 2025;26(6):457-462 | DOI: 10.36290/neu.2025.050

Migraine in children and adolescents: specific features and treatment

MUDr. Hana Medřická, MBA1, 3, MUDr. Zuzana Krška Kušníriková, Ph.D.1, 3, MUDr. Petra Migaľová2, 3
1 Oddělení dětské neurologie FN Ostrava
2 Neurologická klinika FN Ostrava
3 Katedra klinických neurověd, Lékařská fakulta Ostravské univerzity

Migraine is a condition that occurs across all age groups. In the pediatric population, it is underdiagnosed compared to adults. Pediatric migraine has specific neurodevelopmental and clinical characteristics, and its diagnostic and therapeutic approaches differ partially from those used in adults. In this article, we aim to highlight these issues.We present some epidemiological data on migraine occurrence, migraine phenotypes in the pediatric population, diagnostic and treatment approaches, and practical insights, with a broader focus on treatment.

Keywords: headache, migraine, childhood, adolescence, treatment.

Received: April 9, 2025; Revised: June 2, 2025; Accepted: June 2, 2025; Prepublished online: June 2, 2025; Published: December 15, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Medřická H, Krška Kušníriková Z, Migaľová P. Migraine in children and adolescents: specific features and treatment. Neurol. praxi. 2025;26(6):457-462. doi: 10.36290/neu.2025.050.
Download citation

References

  1. Ailani J, Burch RC, Robbins MS; Board of Directors of the American Headache Society. The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. Headache. 2021;61(7):1021-1039. doi:10.1111/head.14153. Go to original source... Go to PubMed...
  2. Al Khalili Y, Asuncion RMD, Chopra P. Migraine Headache in Childhood. In: StatPearls. Treasure Island (FL): StatPearls Publishing; March 4, 2023.
  3. Barnes N, Millman G, James E. Migraine headache in children. Clin Evid. 2006;(15):469-475.
  4. Brar Y, Hosseini SA, Saadabadi A. Sumatriptan. In: StatPearls. Treasure Island (FL): StatPearls Publishing; November 12, 2023.
  5. Burish MJ, Rozen TD. Trigeminal Autonomic Cephalalgias. Neurol Clin. 2019;37(4):847-869. doi:10.1016/j.ncl.2019.07.001. Go to original source... Go to PubMed...
  6. Danhofer P. Dětská neuropsychiatrie v klinické praxi. Praha: Grada Publishing. 2024. ISBN 978-80-247-5018-7.
  7. Greene K, Irwin SL, Gelfand AA. Pediatric Migraine: An Update. Neurol Clin. 2019;37(4):815-833. doi:10.1016/j.ncl.2019.07.009. Go to original source... Go to PubMed...
  8. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. doi:10.1177/0333102417738202. Go to original source... Go to PubMed...
  9. Hershey AD, Powers SW, Vockell AL, et al. PedMIDAS: development of a questionnaire to assess disability of migraines in children. Neurology. 2001;57(11):2034-2039. doi:10.1212/wnl.57.11.2034. Go to original source... Go to PubMed...
  10. Jain S, Malinowski M, Chopra P, et al. Intrathecal drug delivery for pain management: recent advances and future developments. Expert Opin Drug Deliv. 2019;16(8):815-822. doi:10.1080/17425247.2019.1642870. Go to original source... Go to PubMed...
  11. Jeric M, Surjan N, Jelicic Kadic A, et al. Treatment of acute migraine attacks in children with analgesics on the World Health Organization Essential Medicines List: A systematic review and GRADE evidence synthesis. Cephalalgia. 2018;38(9):1592-1607. doi:10.1177/0333102417736902. Go to original source... Go to PubMed...
  12. Lewis DW. Pediatric migraine. Neurol Clin. 2009;27(2):481-501. doi:10.1016/j.ncl.2008.11.003. Go to original source... Go to PubMed...
  13. Ashrafi MR, Salehi S, Malamiri RA, et al. Efficacy and safety of cinnarizine in the prophylaxis of migraine in children: a double-blind placebo-controlled randomized trial. Pediatr Neurol. 2014;51(4):503-508. doi:10.1016/j.pediatrneurol.2014.05.031. Go to original source... Go to PubMed...
  14. Muchová M, Ošlejšková H. Migréna v dětském věku. Neurol. praxi. 2007;3:163-167.
  15. Orr SL, Kabbouche MA, O'Brien HL, et al. Paediatric migraine: evidence-based management and future directions. Nat Rev Neurol. 2018;14(9):515-527. doi:10.1038/s41582-018-0042-7 Go to original source... Go to PubMed...
  16. Pakalnis A. Migraine and Hormones. Semin Pediatr Neurol. 2016;23(1):92-94. doi:10.1016/j.spen.2016.01.005. Go to original source... Go to PubMed...
  17. Pavithra V, Mishra D, Behera S, Juneja M. Paracetamol versus Ibuprofen for the Acute Treatment of Migraine Headache in Children: A Blinded Randomized Controlled Trial. Indian J Pediatr. 2020;87(10):781-786. doi:10.1007/s12098-020-03315-x . Go to original source... Go to PubMed...
  18. Pavkovic IM, Kothare SV. Migraine and Sleep in Children: A Bidirectional Relationship. Pediatr Neurol. 2020;109:20-27. doi:10.1016/j.pediatrneurol.2019.12.013. Go to original source... Go to PubMed...
  19. Rothner AD. Migraine Variants in Children. Pediatr Ann. 2018;47(2):e50-e54. doi:10.3928/19382359-20180126-02. Go to original source... Go to PubMed...
  20. Státní ústav pro kontrolu léčiv [online]. SÚKL: [cit. 20.3.2025]. Available from: https://sukl.gov.cz.
  21. Strnadová T, Matalová P. Migraine in children and its treatment. Pediatr. praxi. 2022;23(6):383-393. https://doi.org/10.36290/ped.2022.069. Go to original source...
  22. Szperka C. Headache in Children and Adolescents. Continuum (Minneap Minn). 2021;27(3):703-731. doi:10.1212/CON.0000000000000993. Go to original source... Go to PubMed...
  23. Teleanu RI, Vladacenco O, Teleanu DM, Epure DA. Treatment of Pediatric Migraine: a Review. Maedica (Bucur). 2016;11(2):136-143.
  24. Youssef PE, Mack KJ. Episodic and chronic migraine in children. Dev Med Child Neurol. 2020;62(1):34-41. doi:10.1111/dmcn.14338. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.